Discover

EKSO
Ekso Bionics Holdings Inc
11.80
2 x 8.44
2 x 13.55
bid
ask
+
0.15
1.29%
2 @ 04:00 PM
12.00 +0.20 (1.69%)
Ytd36.57%
1y96.67%
11.65
day range
11.65
0.50
52 week range
3.13
Open11.40Prev Close11.65Low11.65High11.65Mkt Cap13.31M
Vol95.14KAvg Vol95.96KEPS-0.64P/EN/AForward P/E-3.18
Beta1.48Short Ratio1.03Inst. Own25.25%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-2750-d Avg0.81200-d Avg1.101yr Est5.50
Income Statement
Total Revenue2.14M
Revenues (USD)2.14M
Cost of Revenue1.07M
Gross Profit1.07M
Operating Expenses6.69M
Research and Development Expense583.00K
Selling, General and Administrative Expense6.11M
Operating Income-5.62M
Interest Expense143.00K
Net Income-6.88M
Net Income Common Stock-6.88M
Net Income Common Stock (USD)-6.88M
Consolidated Income-6.88M
Earnings per Basic Share-2.04
Earnings per Basic Share (USD)-2.04
Earnings per Diluted Share-2.04
Earning Before Interest & Taxes (EBIT)-6.74M
Earning Before Interest & Taxes (USD)-6.74M
Weighted Average Shares3.56M
Weighted Average Shares Diluted3.56M
Balance Sheet
Cash and Equivalents3.99M
Cash and Equivalents (USD)3.99M
Trade and Non-Trade Receivables4.54M
Current Assets14.05M
Property, Plant & Equipment Net1.46M
Total Assets19.67M
Debt Current3.68M
Total Debt4.32M
Current Liabilities9.09M
Debt Non-Current641.00K
Total Liabilities13.93M
Accumulated Retained Earnings (Deficit)-269.28M
Accumulated Other Comprehensive Income-482.00K
Shareholders Equity2.09M
Shareholders Equity (USD)2.09M
Assets Non-Current5.62M
Total Debt (USD)4.32M
Deferred Revenue2.84M
Goodwill and Intangible Assets3.85M
Inventory4.65M
Liabilities Non-Current4.84M
Trade and Non-Trade Payables2.11M
Cash Flow
Depreciation, Amortization & Accretion454.00K
Net Cash Flow from Financing4.95M
Net Cash Flow / Change in Cash & Cash Equivalents2.82M
Issuance (Repayment) of Debt Securities -313.00K
Net Cash Flow from Operations-2.12M
Effect of Exchange Rate Changes on Cash -5.00K
Share Based Compensation114.00K